Gallstone disease is a very common gastrointestinal disorder: in fact it has been documented that more than 14% of adults are, or have been, affected by this disease. Therefore, gallstones are a major public health problem, and this disorder is one of the most common and costly of all digestive disease, at least in the Wester World. In fact in terms of inpatient physician services and hospital costs, gallstone disease is by far the most costly digestive disorder, the bulk of the economic burden is mainly due to the surgery, being cholecystectomy considered the treatment of choice for symptomatic gallstones. However, since the introduction of laparoscopic cholecystectomy into clinical practice at the end of 80s, a possible unjustified increase in surgical procedures has been observed. probably due to changes in the perceived risk-benefit ratio (for patients and physicians) and changes in surgical indications. Therefore, there is the need for more knowledge of the epidemiological characteristics of GD in order to better identify therapeutic strategies.
A research article to be published on September 14, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Davide Festi of the University of Bologna has performed the second phase of an epidemiological project (the MICOL project) which is a population-based, cross-sectional study carried out in 8 Italian regions by different operative units.
The project plan includes 2 cross-sectional surveys; the first began in 1985 and was completed in 1988 and the second survey was carried out on the same subjects 10 years later in order to estimate the incidence of gallstone disease. Incidence rate was 0.67% per year, higher in females (0.81%) than in males (0.66%) and it increased with age. Since the study protocol was characterized also by a questionnaire inquiring about the clinical manifestation of the disease, it was possible to confirm that pain in the right hypocondrium and/or epigastrium represents the only symptom significantly associated with gallstones, while the so-called "non-specific biliary symptoms", i.e. dyspeptic symptoms, showed the same frequency in gallstone-free subjects and GD patients. Furthermore, specific symptoms increased in severity and frequency throughout the different stages of gallstone disease (from silent to severe disease). In the studied population, the risk factors for GD in males were increasing age, BMI, concomitant diseases such as diabetes, liver cirrhosis, peptic ulcer and coronary disease, low levels of HDL and total cholesterol, and high levels of triglycerides while, in females, only increasing age and BMI. Increasing age, pain in the right hypocondrium/epigastrium and the presence of concomitant diseases are predictors of GD. Pain in the right hypocondrium or epigastrium was the only symptom associated with GD; symptom severity increased as a function of the natural history of the disease. Increasing age in men and aging and BMI in females were the only predictive factors for the eventual presence of symptoms.
This study has provided data on the incidence, risk factors and clinical manifestations of gallstone disease on a large free-living population. These results may help physicians in clinical decision making, particularly in choosing between different therapeutic strategies (i.e "wait and see", medical treatment, surgical therapy) and in interfering with the risk factors, in particular those related to an unhealthy life style, such as an increased BMI.
Reference: Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, Colecchia A. Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol 2008; 14(34): 5282-5289
Correspondence to: Davide Festi, MD, Dipartimento di Medicina Interna e Gastroenterologia, Policlinico S. Orsola-Malpighi, Via Massarenti 9, Bologna 40138, Italy. email@example.com
Telephone: +39-51-6364123 Fax: +39-51-6364123
About World Journal of Gastroenterology
World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection. It provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th of every month. The WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the title China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.